Segall Bryant & Hamill LLC Invests $2.39 Million in Nutex Health Inc. $NUTX

Segall Bryant & Hamill LLC purchased a new stake in Nutex Health Inc. (NASDAQ:NUTX) in the 3rd quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission. The fund purchased 23,174 shares of the company’s stock, valued at approximately $2,394,000. Segall Bryant & Hamill LLC owned 0.42% of Nutex Health as of its most recent SEC filing.

Several other hedge funds have also added to or reduced their stakes in the business. Bank of America Corp DE lifted its holdings in Nutex Health by 6,590.3% during the fourth quarter. Bank of America Corp DE now owns 2,074 shares of the company’s stock worth $66,000 after acquiring an additional 2,043 shares in the last quarter. Goldman Sachs Group Inc. lifted its holdings in shares of Nutex Health by 17.9% during the 1st quarter. Goldman Sachs Group Inc. now owns 18,119 shares of the company’s stock valued at $852,000 after purchasing an additional 2,748 shares in the last quarter. Jane Street Group LLC bought a new position in shares of Nutex Health during the 1st quarter valued at about $522,000. Geode Capital Management LLC grew its position in shares of Nutex Health by 116.8% in the 2nd quarter. Geode Capital Management LLC now owns 78,859 shares of the company’s stock valued at $9,819,000 after purchasing an additional 42,484 shares during the period. Finally, Police & Firemen s Retirement System of New Jersey bought a new stake in Nutex Health during the 2nd quarter worth approximately $97,000. Institutional investors and hedge funds own 5.32% of the company’s stock.

Nutex Health Price Performance

Shares of NUTX opened at $105.34 on Friday. The company has a quick ratio of 3.18, a current ratio of 3.20 and a debt-to-equity ratio of 0.67. Nutex Health Inc. has a twelve month low of $40.67 and a twelve month high of $193.07. The stock has a market capitalization of $744.75 million, a P/E ratio of 5.70 and a beta of 0.03. The company has a 50 day moving average of $138.40 and a 200-day moving average of $124.53.

Wall Street Analysts Forecast Growth

Several research firms have recently weighed in on NUTX. Wall Street Zen upgraded shares of Nutex Health from a “buy” rating to a “strong-buy” rating in a report on Friday, November 28th. Weiss Ratings reaffirmed a “hold (c)” rating on shares of Nutex Health in a research report on Monday, December 29th. Two equities research analysts have rated the stock with a Buy rating and one has issued a Hold rating to the company. According to MarketBeat, the company has a consensus rating of “Moderate Buy” and a consensus price target of $252.50.

About Nutex Health

Nutex Health, Inc (NASDAQ: NUTX) is an integrated outpatient healthcare services company based in San Antonio, Texas. The company focuses on delivering a range of ambulatory care solutions, including urgent care, telemedicine, medical imaging, teleradiology, weight‐loss services and behavioral health support. By combining in‐person clinics with virtual care capabilities, Nutex Health aims to provide patients with accessible, cost‐effective treatment options outside traditional hospital settings.

The company’s urgent care network operates through both standalone and retail‐anchored centers, offering treatment for non‐life‐threatening injuries and illnesses, preventive screenings and basic primary care.